Company Overview of Adlyfe Inc.
Adlyfe Inc., a biotechnology company, develops diagnostic products for detection of neurodegenerative diseases. The company focuses on developing in vitro diagnostic and imaging tests for Alzheimer’s disease and other neurodegenerative diseases. The company also offers Pronucleon, a platform that uses custom-synthesized peptides that allows signal amplification to map the surface of rare proteins. Adlyfe Inc. was founded in 2003 and is based in Rockville, Maryland.
9430 Key West Avenue
Rockville, MD 20850
Founded in 2003
Key Executives for Adlyfe Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Adlyfe Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.